Board

Thomas Pollare
Thomas Pollare
Chairman of the board since 2020

Born in 1953. M.D. at Karolinska institutet and Ph.D. at Uppsala University. Former CEO Global Medical Investments, former partner with venture capital firm 3i. VP roles at Pharmacia corp. and Schering-Plough Inc. Has also been responsible for market approval of several pharmaceutical products, in various therapeutic areas, that have generated billions in annual sales. International board experience in major corporations as well as start-ups and venture investing.

Cecilia Edström
Cecilia Edström
Board Member since 2021

Born in 1966. BSc at Stockholm School of Economics. Cecilia has extensive experience of operational work in senior positions in several industries. She is the CEO of Bactiguard, a Swedish company with a focus on infection prevention. She has held various roles in the company, including CFO with responsibility for business development, and thus has good insight into specific issues in urology and medical technology in an international market.

Eugen Steiner
Eugen Steiner
Board Member since 2021

Born in 1954. M.D. Ph.D. at Karolinska Institutet. Eugen has over 30 years chief executive management and board work experience in the life science industry  in Scandinavia and USA. He is a venture partner at HealthCap.

Henrik Grönberg
Henrik Grönberg
Board Member since 2021

Born in 1961. Professor cancer epidemiology Karolinska Institutet and senior physician. Henrik is a co-founder of A3P Biomedical, one of the company’s largest owners and a leading expert in prostate cancer. Since 2005, Henrik has been a professor at Karolinska Institutet, where he leads a research group with 35 researchers focused on prostate cancer. He is also responsible for the Prostate Cancer Center at Capio S:t Göran’s Hospital.

Martin Steinberg
Martin Steinberg
Board Member since 2020 & Vice President Corporate Development

Born in 1969. MBA at Stockholm School of Economics. Co-founder of A3P Biomedical AB and one of the company’s largest owners. Martin has more than 15 years’ experience of working in interface between academia and industry. Former Investment Manager with venture capital firm Litorina Kapital and Manager with Arthur D. Little. martin.steinberg@a3pbiomedical.com